Discover more from 4cminewswire’s Newsletter
2023 AUG 31 Ivermectin Worked New Peer-Reviewed Study Proves It
74% REDUCTION IN EXCESS DEATHS.
After being dismissed and maligned, ivermectin gains credibility as a game-changing treatment for COVID-19, with a peer-reviewed study showcasing its impressive 74% reduction in excess deaths.
Special Note: Article Reproduced to combat BigTech Censorship of the Truth about IVM and the author Dr. Joseph Mercola
→ A preprint paper showing ivermectin’s effectiveness against COVID-19 in Peru convinced a group of doctors that widespread ivermectin distribution could end the pandemic in October 2020.
→ Because the paper wasn’t yet peer-reviewed, it was brushed off; ivermectin for COVID-19 was vilified, as were those who dared to prescribe it.
→ Now, the study has been peer-reviewed and published in Cureus, vindicating ivermectin as a treatment for COVID-19.
→ Not only did ivermectin work against COVID-19, it was remarkably effective, resulting in a 74% reduction in excess deaths in the 10 Peru states where it was used most intensively.
→ There was a 14-fold reduction in nationwide excess deaths when ivermectin was readily available and then a 13-fold increase in excess deaths in the two months after ivermectin use was restricted.
As the COVID pandemic wore on, with potential treatments supposedly unknown, New York pulmonologist Dr. Pierre Kory and others tried to get the word out about ivermectin. A widely used antiparasitic drug that’s listed on the World Health Organization’s essential medicines listand approved by the U.S. Food and Drug Administration, ivermectin is widely available, inexpensive and has a long history of safe usage.
In fact, since 1987, 3.7 billion doses of ivermectin have been used among humans worldwide,but it was quickly vilified — as were those who dared to prescribe it. Now, the tables have turned. Not only did ivermectin work against COVID-19, it, was remarkably effective, resulting in a 74% reduction in excess deaths in the 10 states where it was used most intensively.
Ivermectin Dramatically Slashed COVID Deaths
Kory and other physicians with the Front Line COVID-19 Critical Care Working Group (FLCCC) had success early on treating patients with ivermectin and other therapies during the pandemic. His efforts to get the word out on this treatment protocol were stifled by censorship, ridicule and colleagues brainwashed by the official narrative and unwilling to accept the science.
A preprint paper showing ivermectin’s effectiveness against COVID-19 in Peru "was the final piece of evidence which convinced me, Paul [Marik] and the FLCCC that widespread ivermectin distribution could end the pandemic in Oct of 2020," Kory tweeted."Took 2 years but now peer-reviewed & published in a major journal."
That study, published in Cureus,vindicates ivermectin as a treatment for COVID-19. "Reductions in excess deaths over a period of 30 days after peak deaths averaged 74% in the 10 states with the most intensive IVM [ivermectin] use," the study found. It used Peruvian national health data from Peru’s 25 states to evaluate ivermectin’s effects.
A natural experiment was set in motion in May 2020, when Peru authorized ivermectin for COVID-19. The significant reduction in excess deaths noted "correlated closely with the extent of IVM use," the researchers noted.
Global Success Stories Highlight Ivermectin’s Potential
Few have heard about the astonishing success of ivermectin in Uttar Pradesh, India, which embraced large-scale prophylactic and therapeutic use of ivermectin for COVID-19 patients, close contacts of patients and health care workers.
"The possibility of both preventative and treatment efficacies of IVM was raised by outcomes in another world region in which IVM was distributed to the population at risk for COVID-19 on a mass scale. This IVM distribution occurred in Uttar Pradesh, the largest state in India, having a population of 229 million," the study added.
There, widespread ivermectin distribution likely resulted in significantly lower COVID-19 deaths compared to areas not using the drug:
"The cumulative total of COVID-19 deaths per million in population from July 7, 2021 through April 1, 2023 was 4.3 in Uttar Pradesh, as compared with 70.4 in all of India and 1,596.3 in the United States … The much lower number of COVID-19 deaths per population in all of India versus the United States in that period may reflect the use of these same home treatment kits containing IVM, doxycycline, and zinc in some other states of India."
A similar series of events occurred in Itajai, Brazil, a city of 220,000 people. In June 2020, they implemented a prophylaxis program using ivermectin. The program was advertised throughout local media, and people were encouraged to participate and take ivermectin four times a month, on days 1, 2, 15 and 16.
On the appropriate days, they set up tents and centers where people could get the drug, and the entire program was carefully logged in an electronic database. In all, 159,000 Brazilians participated, of those 113,000 elected to take the ivermectin.
Kory and eight coauthors published a paper on the results, which showed "regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates."
Those who used ivermectin had a 44% reduction in COVID-19 infection rate, a 68% reduction in COVID-19 mortality and a 56% reduction in hospitalization rate compared to those who did not.
Meanwhile, a study from Japan demonstrated that just 12 days after doctors were allowed to legally prescribe ivermectin to their COVID-19 patients, cases dropped dramatically.The chairman of the Tokyo Medical Association noticed the low number of infections and deaths in Africa, where many use ivermectin prophylactically and as the core strategy to treat river blindness.
Government’s Ivermectin Restrictions Increased Deaths
In a striking revelation, ivermectin was used against COVID-19 in Peru for four months, before the new president put restrictions on its use. During that time, "there was a 14-fold reduction in nationwide excess deaths and then a 13-fold increase in the two months following the restriction of IVM use."
The U.S. Food and Drug Administration has towed the anti-ivermectin narrative all along, with its infamous tweet reading, "You are not a horse. You are not a cow. Seriously, y’all. Stop it."While commanding the U.S. public and physicians not to use ivermectin for an off-label use, the irony stands that close to 40% of U.S. prescriptions are for off-label uses.
But now, after years of vilification, it had no choice but to admit what’s been right all along — doctors have the authority to prescribe ivermectin for COVID-19. Attorney Jared Kelson of Boyden Gray & Associates, who is representing physicians who have sued the FDA for interfering with their practice of medicine, including relating to ivermectin for COVID-19, explained:
"The fundamental issue is straightforward. After the FDA approves a human drug for sale, does it then have the authority to influence or interfere with how that drug is used within the doctor-patient relationship? The answer is no."
The FDA did just that, nonetheless, but finally admitted the truth on August 16, 2023, tweeting, "Health care professionals generally may choose to prescribe an approved human drug for an unapproved use when they judge that the unapproved use is medically appropriate for an individual patient."
In September 2021, the American Medical Association also told doctors to stop prescribing ivermectin for COVID-19. In a statement, AMA, along with the American Pharmacists Association (APhA) and American Society of Health-System Pharmacists (ASHP), warned:
"We are alarmed by reports that outpatient prescribing for and dispensing of ivermectin have increased 24-fold since before the pandemic and increased exponentially over the past few months. As such, we are calling for an immediate end to the prescribing, dispensing, and use of ivermectin for the prevention and treatment of COVID-19 outside of a clinical trial.
In addition, we are urging physicians, pharmacists, and other prescribers — trusted health care professionals in their communities — to warn patients against the use of ivermectin outside of FDA-approved indications and guidance, whether intended for use in humans or animals, as well as purchasing ivermectin from online stores."
How many died unnecessarily as a result of these commands? As noted by journalist Kim Iversen, even the FDA’s move advising doctors that they’re allowed to prescribe ivermectin for COVID-19 is too little, too late. "Now, two, three years later, too little, too late… ultimately, we now get this study that has been officially peer reviewed and published, and it shows significant, significant, significant reduction [of mortality] in COVID-19."
How Does Ivermectin Work Against COVID?
Ivermectin binds to SARS-CoV-2’s spike protein, limiting the virus’ morbidity and infectivity.The drug, while best known for its antiparasitic effects, also has demonstrated antiviral and anti-inflammatory properties. An in vitro study demonstrated that a single treatment with ivermectin effectively reduced viral load 5,000 times in 48 hours in cell culture.
Studies have shown that ivermectin helps to lower the viral load by inhibiting replication.A single dose of ivermectin can kill 99.8% of the virus within 48 hours. A meta-analysis in the American Journal of Therapeutics also showed the drug reduced infection by an average of 86% when used preventively.
Ivermectin has also been shown to speed recovery, in part by inhibiting inflammation and protecting against organ damage.This pathway also lowers the risk of hospitalization and death. Meta analyses have shown an average reduction in mortality that ranges from 75% to 83%.
Additionally, the drug also prevents transmission of SARS-CoV-2 when taken before or after exposure.As the Cureus study noted, the latest data only adds further evidence that ivermectin has an important place in COVID-19 treatment:
"These encouraging results from IVM treatments in Peru and similar positive indications from Uttar Pradesh, India, which have populations of
It’s worth noting, too, that ivermectin has notable antitumor effects, which include inhibiting proliferation, metastasis and angiogenic activity in cancer cells.It appears to inhibit tumour cells by regulating multiple signalling pathways, which researchers explained in the Pharmacological Research journal, "suggests that ivermectin may be an anticancer drug with great potential."
VIDEO: The War on Ivermectin- Interview with Dr. Pierre Kory and Dr. Mercola
About the Video:
In this interview, return guest Dr. Pierre Kory discusses his new book, “The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the COVID Pandemic.” In it, he details the history of ivermectin and the how and why behind Big Pharma’s suppression of this drug when it was found to work against COVID-19.
In his book, “The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the COVID Pandemic,” Dr. Pierre Kory details the history of ivermectin and the how and why behind Big Pharma’s suppression of this drug when it was found to work against COVID-19.
After spending his career as an internist and critical care physician, Kory has now turned his attention to long-haul COVID and post-jab injury syndromes.
Daily ivermectin use is a mainstay of the treatment plans for long-haulers and those with COVID jab injuries, as the drug very effectively binds to the toxic spike protein that is causing most of the damage in both of these conditions.
Methylene blue can be helpful for those struggling with crippling fatigue, as it boosts mitochondrial respiration and improves energy metabolism. It’s actually the parent molecule for hydroxychloroquine and chloroquine, off-patent drugs used to treat COVID-19 along with zinc.
“The War on Ivermectin” reveals the disinformation playbook used by Big Pharma and its many allies to suppress highly useful and inexpensive medicines in order to protect and increase corporate profits.
Interview Transcript DOWNLOAD
Why Was Ivermectin Suppressed?
Reason: GENERIC DRUGS Brings No Profits for Big Pharma
The average treatment cost for ivermectin is $58.35
Do you think this has anything to do with ivermectin’s vilification?
The authors of the Cureus study certainly do:
"The exceptional safety profile and low cost of IVM certainly support its use as in Peru’s operation MOT [Mega-Operación Tayta] and in Uttar Pradesh as an attractive national policy for COVID-19 mitigation. These significant reductions in mortality as achieved in Peru and Uttar Pradesh suggest that the impact of such a national IVM deployment would be observable within a relatively short period.
REASON: PATENTED DRUGS Brings Profits for Big Pharma Hence a Bias Via Manipulated Science is Applied.
However, generic drugs have often fared poorly in competition with patented offerings in past decades, based upon the unfortunate vulnerability of science to commodification and regulatory capture … Such a potential bias against IVM was suggested by a February 4, 2021 press release from Merck, which was then developing its own patented COVID-19 therapeutic, claiming that there was ‘a concerning lack of safety data’ for IVM.
However, IVM is Merck’s own drug, found safe at doses considerably higher than its standard dose in several studies, as cited in the section on the background on IVM treatments of COVID-19, and the Nobel Prize committee specifically noted IVM’s safety record in honouring the discovery of this drug in its 2015 prize for medicine."
If you’d like to learn more about ivermectin’s potential uses for COVID-19, FLCCC’s I-CARE protocol can be downloaded in full,giving you step-by-step instructions on how to prevent and treat the early symptoms of COVID-19.
DR. JOSEPH MERCOLA DISCLAIMER:
The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked.
The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Mercola and his community. Dr. Mercola encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional. The subscription fee being requested is for access to the articles and information posted on this site, and is not being paid for any individual medical advice.
If you are pregnant, nursing, taking medication, or have a medical condition, consult your health care professional before using products based on this content.
Ivermectin Worked New Peer-Reviewed Study Proves It Original Source READ HERE
FN03 WND August 19, 2023 https://www.wnd.com/2023/08/new-study-shows-ivermectin-use-resulted-74-reduction-excess-deaths/
FN04 Substack, The Vigilant Fox August 15, 2023
FN07 Indian Express May 12, 2021 https://indianexpress.com/article/cities/lucknow/uttar-pradesh-government-says-ivermectin-helped-to-keep-deaths-low-7311786/
FN10 Cureus. 2022 Jan; 14(1): e21272 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765582/
FN11 Cureus. 2022 Jan; 14(1): e21272 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765582/
FN12 YouTube, November 23, 2021 Min 1:25
FN14 World Health Organization, Onchocerciasis https://www.who.int/news-room/fact-sheets/detail/onchocerciasis
FN16 Twitter, Broken Truth August 13, 2023
FN17 Courthouse News Service August 8, 2023 https://www.courthousenews.com/ivermectin-proponents-ask-fifth-circuit-to-revive-lawsuit-against-fda/
FN18 Courthouse News Service August 8, 2023 https://www.courthousenews.com/ivermectin-proponents-ask-fifth-circuit-to-revive-lawsuit-against-fda/
FN19 Twitter, U.S. FDA August 16, 2023
FN21 Twitter, FLCCC August 15, 2023
FN23 Antiviral Research, 2020;178(104787) https://www.sciencedirect.com/science/article/pii/S0166354220302011
FN24 FLCCC Summary of Clinical Trials Evidence for Ivermectin in COVID-19 (PDF) https://www.scstatehouse.gov/CommitteeInfo/SenateMedicalAffairsCommittee/One-Page-Summary-of-the-Clinical-Trials-Evidence-for-Ivermectin-in-COVID-19%20%20%20%20(3).pdf
FN25 News-Medical.net, April 6, 2020 https://www.news-medical.net/news/20200406/Antiparasitic-drug-Ivermectin-kills-coronavirus-in-48-hours.aspx
FN26 American Journal of Therapeutics, 2021;28(4) Therapeutic Advances https://journals.lww.com/americantherapeutics/Fulltext/2021/08000/Ivermectin_for_Prevention_and_Treatment_of.7.aspx
FN27 Front Line COVID-19 Critical Care Alliance, August 29, 2021 https://www.scstatehouse.gov/CommitteeInfo/SenateMedicalAffairsCommittee/SUMMARY-OF-THE-EVIDENCE-BASE-FINAL.pdf
28 FLCCC January 7, 2021 Press Release (PDF) https://web.archive.org/web/20220305223515/https:/covid19criticalcare.com/wp-content/uploads/2021/01/FLCCC-PressRelease-NIH-C19-Panel-FollowUp-Jan7-2021.pdf
29 Swiss Policy Research December 31, 2020 https://swprs.org/who-preliminary-review-confirms-Ivermectin-effectiveness/
FN30 Evidence-Based Medicine Consultancy Ltd. Rapid Review and Meta-Analysis January 3, 2021 (PDF) https://b3d2650e-e929-4448-a527-4eeb59304c7f.filesusr.com/ugd/593c4f_8cb655bd21b1448ba6cf1f4c59f0d73d.pdf
FN31 FLCCC Summary of Clinical Trials Evidence for Ivermectin in COVID-19 (PDF) https://www.scstatehouse.gov/CommitteeInfo/SenateMedicalAffairsCommittee/One-Page-Summary-of-the-Clinical-Trials-Evidence-for-Ivermectin-in-COVID-19%20%20%20%20(3).pdf
FN33.01 Pharmacol Res. 2021 Jan; 163: 105207 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
FN33.02 Pharmacol Res. 2021 Jan; 163: 105207 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
35 JAMA 2022;327(6):584-587 https://jamanetwork.com/journals/jama/fullarticle/2788253
FN37 FLCCC Alliance, I-CARE https://covid19criticalcare.com/protocol/i-care-early-covid-treatment/